ACORDA THERAPEUTICS INC (ACOR) Stock Analyst Ratings
USA - NASDAQ:ACOR - US00484M7002 - Common Stock
0.661 USD
-0.22 (-24.86%)
0.5656 USD
-0.1 (-14.43%)
ChartMill assigns a Buy % Consensus number of 83% to ACOR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 10.2. This target is 1443.12% above the current price.
ACOR was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about ACOR.
In the previous month the buy percentage consensus was at a similar level.
ACOR was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2021-06-17 | HC Wainwright & Co. | Upgrade | Neutral -> Buy |
ACORDA THERAPEUTICS INC / ACOR FAQ
What is the price target for ACOR stock?
7 analysts have analysed ACOR and the average price target is 10.2 USD. This implies a price increase of 1443.12% is expected in the next year compared to the current price of 0.661.
How do analysts rate ACORDA THERAPEUTICS INC (ACOR)?
The consensus rating for ACORDA THERAPEUTICS INC (ACOR) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.
Can you provide the analyst count for ACORDA THERAPEUTICS INC stock?
The number of analysts covering ACORDA THERAPEUTICS INC (ACOR) is 7.